Cargando…

Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience

BACKGROUND: Tumours on the scalp are diverse and often exhibit site- and histology-specific characteristics. Reconstructing the scalp after oncological resection has always been challenging because of its unique anatomy. METHODOLOGY: A retrospective review of patients with malignant scalp tumour ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Varghese, Bipin T., Nadarajan, Abinaya R., Thomas, Shaji, Iype, Elizabeth Mathew, George, Nebu Abraham, K. M., Jagathnath Krishna, Lal, Sahya S., Somanathan, Thara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580575/
https://www.ncbi.nlm.nih.gov/pubmed/37845728
http://dx.doi.org/10.1186/s12957-023-03200-9
_version_ 1785121970823626752
author Varghese, Bipin T.
Nadarajan, Abinaya R.
Thomas, Shaji
Iype, Elizabeth Mathew
George, Nebu Abraham
K. M., Jagathnath Krishna
Lal, Sahya S.
Somanathan, Thara
author_facet Varghese, Bipin T.
Nadarajan, Abinaya R.
Thomas, Shaji
Iype, Elizabeth Mathew
George, Nebu Abraham
K. M., Jagathnath Krishna
Lal, Sahya S.
Somanathan, Thara
author_sort Varghese, Bipin T.
collection PubMed
description BACKGROUND: Tumours on the scalp are diverse and often exhibit site- and histology-specific characteristics. Reconstructing the scalp after oncological resection has always been challenging because of its unique anatomy. METHODOLOGY: A retrospective review of patients with malignant scalp tumour operated on at a single institution over 10 years was performed. Data were collected and analysed regarding the scalp tumour profile, treatment, and the outcome of these procedures. RESULTS: Of the 66 patients in our study, 33 (50%) had SCC. In addition to this, 21% were sarcomas, 17% were appendageal carcinomas, 11% were BCCs, and 1% was neuroendocrine carcinoma. Cortical erosion was observed in 6 patients in the CT imaging, all with SCC histology. Among the eight patients with pathological nodal involvement, three had angiosarcoma, three had SCC, one had appendageal carcinoma, and one had neuroendocrine carcinoma. The mean surgical defect size was 67.4 cm(2). The surgical defect was reconstructed with local flaps in 58% of patients and primary closure in 27%. Local and systemic recurrence was noted in 25% of patients. Tumour size more than 6 cm, tumour histology (SCC & sarcoma), unplanned margin-positive excision, and residual disease in re-excision had higher recurrence, even though the p-value was not significant. CONCLUSION: Scalp tumours are heterogeneous in their clinical profiles. Often, its tumour biology and microscopic extent are underestimated. High suspicion, histological diagnosis, and clear surgical margins are all requirements in successfully treating scalp tumours. In order to minimize morbidity and restore an aesthetic and functional outcome, it is critical to use the simplest scalp reconstruction whenever possible.
format Online
Article
Text
id pubmed-10580575
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105805752023-10-18 Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience Varghese, Bipin T. Nadarajan, Abinaya R. Thomas, Shaji Iype, Elizabeth Mathew George, Nebu Abraham K. M., Jagathnath Krishna Lal, Sahya S. Somanathan, Thara World J Surg Oncol Research BACKGROUND: Tumours on the scalp are diverse and often exhibit site- and histology-specific characteristics. Reconstructing the scalp after oncological resection has always been challenging because of its unique anatomy. METHODOLOGY: A retrospective review of patients with malignant scalp tumour operated on at a single institution over 10 years was performed. Data were collected and analysed regarding the scalp tumour profile, treatment, and the outcome of these procedures. RESULTS: Of the 66 patients in our study, 33 (50%) had SCC. In addition to this, 21% were sarcomas, 17% were appendageal carcinomas, 11% were BCCs, and 1% was neuroendocrine carcinoma. Cortical erosion was observed in 6 patients in the CT imaging, all with SCC histology. Among the eight patients with pathological nodal involvement, three had angiosarcoma, three had SCC, one had appendageal carcinoma, and one had neuroendocrine carcinoma. The mean surgical defect size was 67.4 cm(2). The surgical defect was reconstructed with local flaps in 58% of patients and primary closure in 27%. Local and systemic recurrence was noted in 25% of patients. Tumour size more than 6 cm, tumour histology (SCC & sarcoma), unplanned margin-positive excision, and residual disease in re-excision had higher recurrence, even though the p-value was not significant. CONCLUSION: Scalp tumours are heterogeneous in their clinical profiles. Often, its tumour biology and microscopic extent are underestimated. High suspicion, histological diagnosis, and clear surgical margins are all requirements in successfully treating scalp tumours. In order to minimize morbidity and restore an aesthetic and functional outcome, it is critical to use the simplest scalp reconstruction whenever possible. BioMed Central 2023-10-17 /pmc/articles/PMC10580575/ /pubmed/37845728 http://dx.doi.org/10.1186/s12957-023-03200-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Varghese, Bipin T.
Nadarajan, Abinaya R.
Thomas, Shaji
Iype, Elizabeth Mathew
George, Nebu Abraham
K. M., Jagathnath Krishna
Lal, Sahya S.
Somanathan, Thara
Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience
title Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience
title_full Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience
title_fullStr Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience
title_full_unstemmed Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience
title_short Spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience
title_sort spectrum of malignant scalp tumours and its impact on management—a tertiary care cancer centre experience
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580575/
https://www.ncbi.nlm.nih.gov/pubmed/37845728
http://dx.doi.org/10.1186/s12957-023-03200-9
work_keys_str_mv AT varghesebipint spectrumofmalignantscalptumoursanditsimpactonmanagementatertiarycarecancercentreexperience
AT nadarajanabinayar spectrumofmalignantscalptumoursanditsimpactonmanagementatertiarycarecancercentreexperience
AT thomasshaji spectrumofmalignantscalptumoursanditsimpactonmanagementatertiarycarecancercentreexperience
AT iypeelizabethmathew spectrumofmalignantscalptumoursanditsimpactonmanagementatertiarycarecancercentreexperience
AT georgenebuabraham spectrumofmalignantscalptumoursanditsimpactonmanagementatertiarycarecancercentreexperience
AT kmjagathnathkrishna spectrumofmalignantscalptumoursanditsimpactonmanagementatertiarycarecancercentreexperience
AT lalsahyas spectrumofmalignantscalptumoursanditsimpactonmanagementatertiarycarecancercentreexperience
AT somanathanthara spectrumofmalignantscalptumoursanditsimpactonmanagementatertiarycarecancercentreexperience